Home > News > Study Using Nanogen Assay
June 8th, 2005
Abstract:
Nanogen, Inc. today announced that a study published in the European Journal of Heart Failure concluded that for patients with severe congestive heart failure, a significantly higher risk of one-year mortality was associated with elevated levels of N-terminal brain natriuretic peptide (NT-proBNP).
Source:
prnewswire
Bookmark:
| Related News Press |
Announcements
Nanosensors could help determine tumors’ ability to remodel tissue: Measuring enzyme levels could help doctors select appropriate treatments September 29th, 2016
Innovation in Nanotechnology is Focus of Symposium: Annual event brings international experts to Northwestern Oct. 6 September 29th, 2016
Cambrios at CEATEC - Japan 2016 September 29th, 2016
Picosun patents ALD nanolaminate to prevent electronics from overheating September 28th, 2016
Tools
Oxford Instruments systems now facilitate water purification technology September 27th, 2016
Dr Barbara Armbruster promoted to Worldwide Sales and Marketing Director for XEI Scientific September 27th, 2016
Oxford Instruments is ‘Bringing the Nanoworld Together’ in India once again - 22 - 23 November 2016 | IISc Bangalore September 21st, 2016
Bruker Introduces Complete Commercial AFM-Based SECM Solution: PeakForce SECM Mode Enables Previously Unobtainable Electrochemical Information September 20th, 2016
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
University Technology Transfer & Patents
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||
